PharmAbcine delivered a presentation at Access China Biotech Forum, September 23-30, 2021.

Dr. Hyunsun Park, Chief Brand Officer and Chief Operation Officer of PharmAbcine, introduces PharmAbcine’s key antibody drug candidates, such as Olinvacimab, PMC-309, and PMC-403.

Click the link for the video (Eng/Kor Sub available)

https://youtu.be/Uemqg0B9OXs